Home → Peptides → TB-500 → How Is It Made?

TB-500 Topics

How Is TB-500 Made?

Overview of TB-500 Synthesis

TB-500 is produced through solid-phase peptide synthesis (SPPS), a chemical method that allows for the sequential assembly of amino acids into peptide chains. This synthetic approach offers several advantages over extraction from biological sources, including higher purity, better consistency, and the ability to produce large quantities. The 43-amino acid sequence of TB-500 makes it a moderately challenging synthesis, requiring careful optimization and quality control.

Solid-Phase Peptide Synthesis (SPPS)

The Basic Process

SPPS involves building the peptide chain one amino acid at a time while the growing chain is attached to a solid support (typically a resin bead). The process includes:

  • Attachment: The first amino acid is attached to the solid support
  • Deprotection: Protective groups are removed from the amino acid
  • Coupling: The next amino acid is chemically linked to the growing chain
  • Repetition: Steps 2-3 are repeated for each amino acid in the sequence
  • Cleavage: The completed peptide is cleaved from the solid support
  • Purification: The crude peptide is purified to remove impurities

Fmoc vs. Boc Chemistry

Two main protection strategies are used in SPPS:

  • Fmoc (Fluorenylmethyloxycarbonyl): Most commonly used for TB-500 synthesis
    • Removed with mild base (piperidine)
    • Compatible with acid-labile side chain protecting groups
    • Generally preferred for longer peptides
  • Boc (tert-Butyloxycarbonyl): Alternative approach
    • Removed with strong acid (TFA)
    • Requires different side chain protection strategy
    • Less commonly used for TB-500

Step-by-Step Synthesis Process

1. Resin Loading

The C-terminal amino acid (serine for TB-500) is attached to the solid support resin. The resin choice depends on the desired C-terminal modification (free acid, amide, etc.).

2. Deprotection Cycles

For each amino acid addition:

  • The Fmoc protecting group is removed with piperidine solution
  • The resin is washed to remove deprotection reagents
  • The free amine is now ready for the next coupling

3. Coupling Reactions

The next protected amino acid is activated and coupled to the growing chain:

  • Activation: The amino acid's carboxyl group is activated using coupling reagents (e.g., HBTU, HATU, DIC)
  • Coupling: The activated amino acid reacts with the free amine on the resin
  • Monitoring: Coupling efficiency is monitored (e.g., Kaiser test, UV monitoring)
  • Capping: Any unreacted amines may be capped to prevent deletion sequences

4. Repetition

Steps 2-3 are repeated 42 times to build the complete 43-amino acid sequence of TB-500, working from C-terminus to N-terminus.

5. N-Terminal Acetylation

Natural Thymosin Beta-4 has an acetylated N-terminus. This modification is typically added after the final amino acid coupling using acetic anhydride.

6. Cleavage from Resin

The completed peptide is cleaved from the solid support using a cleavage cocktail (typically TFA with scavengers like water, triisopropylsilane, and ethanedithiol). This also removes side chain protecting groups.

7. Precipitation and Washing

The cleaved peptide is precipitated (usually with cold ether) and washed to remove cleavage reagents and small molecule impurities.

Purification Methods

High-Performance Liquid Chromatography (HPLC)

The primary purification method for TB-500:

  • Reverse-Phase HPLC: Most common approach
    • Separates peptides based on hydrophobicity
    • Uses water-acetonitrile gradients with TFA
    • Can achieve >95% purity
  • Preparative vs. Analytical:
    • Preparative HPLC for large-scale purification
    • Analytical HPLC for quality control

Additional Purification Steps

  • Desalting: Removal of salts and small molecules
  • Lyophilization: Freeze-drying to produce stable powder
  • Re-purification: Multiple HPLC runs may be needed for highest purity

Quality Control and Analysis

Analytical Techniques

Multiple methods are used to verify TB-500 identity, purity, and quality:

  • Mass Spectrometry (MS):
    • Confirms molecular weight (4963.44 g/mol)
    • Identifies sequence errors or modifications
    • MALDI-TOF or ESI-MS commonly used
  • Analytical HPLC:
    • Determines purity percentage
    • Identifies impurities and degradation products
    • Monitors batch-to-batch consistency
  • Amino Acid Analysis:
    • Confirms amino acid composition
    • Verifies peptide content
  • Peptide Sequencing:
    • Confirms correct amino acid sequence
    • Detects sequence errors

Purity Specifications

TB-500 purity is typically specified as:

  • Research Grade: ≥95% purity by HPLC
  • High Purity: ≥98% purity
  • Pharmaceutical Grade: ≥99% purity (for clinical development)

Manufacturing Challenges

Sequence-Related Challenges

TB-500's 43-amino acid length presents several challenges:

  • Cumulative Coupling Efficiency: Each coupling must be highly efficient to avoid deletion sequences
  • Aggregation: Longer peptides are more prone to aggregation during synthesis
  • Purification Complexity: More potential impurities to separate

Specific Amino Acid Challenges

  • Methionine: Susceptible to oxidation
  • Aspartic Acid: Can undergo aspartimide formation
  • Proline: Can cause coupling difficulties

Scale of Production

Laboratory Scale

  • Milligram to gram quantities
  • Manual or semi-automated synthesizers
  • Typical for research applications

Commercial Scale

  • Gram to kilogram quantities
  • Automated synthesizers
  • GMP facilities for clinical development

Quality Variations in the Market

Factors Affecting Quality

TB-500 quality can vary significantly between suppliers:

  • Synthesis Expertise: Skill and experience of the manufacturer
  • Raw Material Quality: Quality of amino acids and reagents used
  • Purification Rigor: Extent and thoroughness of purification
  • Quality Control: Analytical testing performed
  • Storage and Handling: Proper storage conditions maintained

Common Quality Issues

  • Low Purity: Presence of deletion sequences, truncated peptides, or other impurities
  • Incorrect Sequence: Amino acid substitutions or deletions
  • Degradation: Oxidation, deamidation, or other modifications
  • Contamination: Bacterial endotoxins, solvents, or other contaminants
  • Incorrect Concentration: Actual peptide content differs from label claim

Storage and Stability

Lyophilized (Powder) Form

  • Store at -20°C or colder
  • Protect from light and moisture
  • Stable for 1-2 years when properly stored
  • Desiccant packets help maintain dryness

Reconstituted Form

  • Store at 2-8°C (refrigerated)
  • Use within 2-4 weeks
  • Protect from light
  • Avoid repeated freeze-thaw cycles

Comparison with Related Peptides

TB-500's synthesis is similar to other therapeutic peptides like BPC-157 (15 amino acids) and GHK-Cu (3 amino acids), though TB-500's greater length makes it more challenging to synthesize with high purity. The principles of SPPS are the same, but longer peptides require more optimization and quality control.

Conclusion

TB-500 is manufactured through solid-phase peptide synthesis, a well-established chemical method that allows for production of this 43-amino acid peptide with high purity. The synthesis requires expertise, quality raw materials, and rigorous purification and quality control. Significant variations in quality exist between suppliers, making third-party testing important for verifying peptide identity, purity, and quality. Proper storage and handling are essential for maintaining peptide stability and activity.

← Back to TB-500 Overview